Pharma’s tough exit strategy in Russia
Share Now on:
Pharmaceutical companies are weighing how to dissociate themselves from Russia's government while providing lifesaving medications to everyday Russians.
Segments From this episode
Bringing the economy in for a "soft landing" — taming inflation without bringing on a recession — has proven difficult for the Fed in the past.
Ukraine’s economy is being strangled, says Natalie Jaresko, citing the need for international support as well as Russian reparations.
Drugmakers have pulled some nonlifesaving products, hesitating to punish ordinary Russians by withdrawing vital treatments.
The price of diesel is up 50% over a year ago. Some districts are turning to COVID relief funds to cover the increased cost.
Russia makes steel the dirty, old-fashioned way. Europe hoped its trade relationship could spur a cleanup.
Russia invading Ukraine is a big reason that prices skyrocketed.. But it's not the whole story.